ArticleGastroenterology research and practice2025
Modification of the Low FODMAP Diet Is Feasible in the Treatment of Irritable Bowel Syndrome: A Randomised Crossover Study.
Article in Gastroenterology research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05618106 (Modification of the Low FODMAP Diet in Treatment of Irritable Bowel Syndrome), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Modification of the Low FODMAP Diet in Treatment of Irritable Bowel Syndrome: A Randomised Cross-over Study
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Irritable bowel syndrome (IBS) can be dietary managed by applying restrictions in the diet of fermentable oligosaccharides, disaccharides, monosaccharides and polyols-the low FODMAP diet. However, many patients have major difficulties integrating the diet into their daily lives. Objective: We aimed to investigate if the three carbohydrate groups eliminated in the traditional low FODMAP diet are equally important in relieving gastrointestinal symptoms in IBS. Methods: Nine patients with IBS according to the Rome IV criteria and referred to specialised diet therapy in private clinics were randomised in a crossover design to three different carbohydrate-modified diets: (A) low polyol diet, (B) low FOS + GOS diet and (C) low standard FODMAP diet for 4 weeks on each diet. Symptoms were assessed by the Birmingham IBS questionnaire and adequate relief (IBS-AR) and quality of life by the IBS Quality of Life Scale questionnaire (IBS-QOL) at baseline and after every intervention period by a dietitian with assessment of the intake by weekly contact. Nonparametric statistical methods were used. Results: Compared to baseline, the low polyol diet did not change the symptoms, but relief was significant on both the low FOS + GOS diet and the low FODMAP diet ( Conclusion: A carbohydrate-modified diet with the exclusion of fructooligosaccharides and galactooligosaccharides (low FOS + GOS diet) reduced gastrointestinal symptoms and improved quality of life equally to the standard low FODMAP diet in patients with IBS. Polyol restriction was of minor importance. The low FOS + GOS diet could be the starting diet in selected patients with IBS. Trial Registration: ClinicalTrials.gov identifier: NCT05618106.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.